Surface Guided Radiation Therapy (SGRT) Devices Market SIze and Scope Analysis Report 2025 to 2034
Segmentation of Surface Guided Radiation Therapy (SGRT) Devices Market-
Surface Guided Radiation Therapy (SGRT) Devices Market By Offerings-
- Hardware
- Camera / Detector Pods
- In-Bore Cameras
- Pattern Projectors
- Workstation & Mounting
- Software & Clinical Modules
- Base Platform Licence
- Gating / DIBH Module
- Motion-Monitoring Module
- Coaching / Visualisation Module
- Planning-Clearance Module
- Stereotactic / SRS Module
- Reporting / QA Module
- Services & Recurring
- Installation & Commissioning
- Applications Training
- Service / Maintenance Contracts
- Software Subscriptions / Upgrades
Surface Guided Radiation Therapy (SGRT) Devices Market By System/Deployment Type-
- CT-Simulation Surface Systems
- Treatment-Room Surface Systems — Conventional C-arm LINAC
- In-Bore / Ring-Gantry & MR-Linac Surface Systems
- Proton & Particle-Therapy Surface Systems
Surface Guided Radiation Therapy (SGRT) Devices Market By End User-
- Hospital-Based & Academic Radiation-Oncology Departments
- Independent & Private Cancer / Radiotherapy Centres
- Proton & Particle-Therapy Centres
- Government & Public Cancer Institutes & Research Centres
Surface Guided Radiation Therapy (SGRT) Devices Market By Region-
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Chapter 1. Executive Summary
1.1. Market Snapshot & Key Findings, 2025–2035
1.2. Market Size & Growth Outlook — Value (US$ Mn), 2022–2035
1.3. Offering Highlights — Hardware, Software & Clinical Modules, Services & Recurring
1.4. Software-Module Attach & Recurring-Revenue Opportunity Analysis
1.5. Deployment Highlights — CT-Simulation, Treatment-Room, In-Bore/MR-Linac & Proton
1.6. Competitive Landscape Synopsis — Core, Emerging, Regional & Adjacent Players
1.7. Analyst Takeaways & Strategic Imperatives for Suppliers, OEMs & Investors
Chapter 2. Report Scope, Definitions & Research Framework
2.1. Market Definition & Supplier-Revenue Boundary
2.2. Inclusion & Exclusion Criteria — What Counts as an SGRT Sale
2.3. Defining SGRT — Optical Surface Tracking, Gating/DIBH & Motion Monitoring
2.4. Scope Disambiguation — SGRT vs LINAC/CT-Simulator/Proton Machines vs Non-Surface Image Guidance
2.5. Offering Classes — Hardware, Software & Clinical Modules, Services & Recurring
2.6. Anti-Double-Counting Rules — Offering vs Deployment Type, Bundled Modules & Single-Recognition Rule
2.7. Software Module Attribution — Standalone License vs Base Platform Bundle
2.8. Key Study Assumptions
2.9. Years Considered — Historical, Base, Estimated & Forecast Period
2.10. Currency, Value Units, Rounding & Forecast Conventions
2.11. Unit-of-Measure Definitions — Value (US$ Mn) & Installed Systems (Units)
2.12. Offering MECE Segmentation Architecture & Overlap-Elimination Logic
2.13. Segment Feasibility Assessment — Sized Axes vs Supporting Metrics
2.14. Why Offering and Deployment Type Are Separate, Non-Additive Axes
2.15. Research Methodology — Summary & Study Limitations
Chapter 3. Market Introduction, SGRT Workflow & Value Chain
3.1. What SGRT Is — Dose-Free Optical Surface Tracking in Radiation Oncology
3.2. Clinical Workflow — Patient Setup, Motion Monitoring, Gating/DIBH & Intra-Fraction Control
3.3. SGRT Applications Across CT-Simulation, Treatment Room, In-Bore/MR-Linac & Proton Systems
3.4. Hardware, Software Modules & Services — SGRT Offering Stack
3.5. Clinical Value — Accuracy, Tattoo-Free Setup, DIBH Cardiac Sparing & SRS/SBRT Enablement
3.6. SGRT Value Chain — Component Suppliers, SGRT Vendors, LINAC OEMs & Radiation Oncology Centres
3.7. Regulatory & Quality Context — FDA/CE, Medical Device Software & QA Standards
3.8. Reimbursement & Procurement Dynamics Across Care Settings
Chapter 4. Market Dynamics
4.1. Market Drivers
4.1.1. Rising Adoption of DIBH for Breast & Thoracic Cardiac Sparing
4.1.2. Growth of SRS/SBRT and Hypofractionation Requiring Precise Motion Control
4.1.3. Tattoo-Free Setup, Patient Comfort & Workflow Efficiency Benefits
4.1.4. Expansion of Radiotherapy Installed Base and Centre Modernisation
4.1.5. Rising Software Revenue and Multi-Module Attach Opportunities
4.2. Market Challenges & Restraints
4.2.1. High Capital Cost and Budget Constraints in Radiation Oncology Centres
4.2.2. Integration and Interoperability Challenges with LINAC/OIS Platforms
4.2.3. Reimbursement Variability and Clinical Evidence Requirements
4.2.4. Skilled Physicist Requirements and Training Needs
4.3. Market Opportunities
4.3.1. Software Module Expansion and Subscription-Based Revenue Models
4.3.2. In-Bore, MR-Linac and Proton Surface Guidance Adoption
4.3.3. Emerging Market Radiotherapy Capacity Expansion
4.3.4. AI-Assisted Motion Prediction and Automated QA
4.4. Emerging Trends — Software-Led Growth, AI Motion Prediction, In-Bore/MR & Proton SGRT, Subscription Models
4.5. Impact Analysis of Market Dynamics (2026 vs 2035)
Chapter 5. Premium Insights — Software Attach, Installed Base & Deployment Dashboard
5.1. Software Module Attach-Rate Model — Modules per System & Recurring Revenue
5.2. Installed Base & Replacement Map — SGRT Systems by Deployment and Region
5.3. Hardware vs Software vs Services Value Split & Margin Pool Analysis
5.4. Offering vs Deployment Matrix — Demand Analysis Without Double Counting
5.5. LINAC OEM Embedded vs Pure-Play Surface Guidance Dynamics
5.6. Ownership & M&A Overlay — Radiation Oncology Technology Consolidation
5.7. Top Strategic Questions Addressed by the Market Study
Chapter 6. Market Factor & Strategic Analysis
6.1. Porter’s Five Forces Analysis
6.2. PESTEL Analysis
6.3. Value Chain & Margin Pool Analysis — Hardware, Software & Services
6.4. Pricing Analysis — Offering, Module & Deployment Type
6.5. Installed Base, Attach Rate & Recurring Revenue Analysis
6.6. Regulatory & Quality Landscape — FDA/CE, SaMD & QA Requirements
6.7. Technology & Innovation Pipeline — AI Motion Prediction, In-Bore/MR & Proton SGRT
6.8. Investment, M&A & Strategic Alliances, 2022–2026
6.9. Patent & R&D Landscape by Country and Company
6.10. Incremental Opportunity Analysis — Value (US$ Mn), 2026–2035
6.11. Competitive Positioning Map & Revenue Signal Analysis (2025)
Chapter 7. Global Market Analysis & Forecast, By Offering
7.1. Overview, Allocation Rule & Single-Recognition Logic
7.2. Market Share by Offering, 2025 & 2035
7.3. Market Size — Value (US$ Mn), 2022–2035
7.3.1. Hardware
7.3.1.1. Camera / Detector Pods
7.3.1.2. In-Bore Cameras
7.3.1.3. Pattern Projectors
7.3.1.4. Workstation & Mounting Systems
7.3.2. Software & Clinical Modules
7.3.2.1. Base Platform Licence
7.3.2.2. Gating / DIBH Module
7.3.2.3. Motion-Monitoring Module
7.3.2.4. Coaching / Visualisation Module
7.3.2.5. Planning-Clearance Module
7.3.2.6. Stereotactic / SRS Module
7.3.2.7. Reporting / QA Module
7.3.3. Services & Recurring
7.3.3.1. Installation & Commissioning
7.3.3.2. Applications Training
7.3.3.3. Service / Maintenance Contracts
7.3.3.4. Software Subscriptions / Upgrades
7.4. Control-Total Reconciliation — Offering Lines vs Global Market Value
7.5. Recurring vs One-Time Revenue Bridge, 2026–2035
Chapter 8. Global Market Analysis & Forecast, By System / Deployment Type
8.1. Overview & Allocation Rule
8.2. Market Share by Deployment Type, 2025 & 2035
8.3. Market Size — Value (US$ Mn), 2022–2035
8.3.1. CT-Simulation Surface Systems
8.3.2. Treatment-Room Surface Systems — Conventional LINAC
8.3.3. In-Bore / Ring-Gantry & MR-Linac Surface Systems
8.3.4. Proton & Particle-Therapy Surface Systems
Chapter 9. Global Market Analysis & Forecast, By End User
9.1. Overview & Allocation Rule
9.2. Market Share by End User, 2025 & 2035
9.3. Market Size — Value (US$ Mn), 2022–2035
9.3.1. Hospital-Based & Academic Radiation Oncology Departments
9.3.2. Independent & Private Cancer / Radiotherapy Centres
9.3.3. Proton & Particle Therapy Centres
9.3.4. Government & Public Cancer Institutes & Research Centres
Chapter 10. Global Market Analysis & Forecast, By Region
10.1. Global Market Snapshot, 2025 & 2035
10.2. North America
United States
Canada
Mexico
10.3. Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
10.4. Asia Pacific
China
Japan
India
South Korea
Australia
Rest of Asia Pacific
10.5. Latin America
Brazil
Mexico
Argentina
Rest of Latin America
10.6. Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa
10.7. Installed Base & Adoption Cross-Tab Analysis by Region
Chapter 11. Competitive Landscape & Company Screen
11.1. Market Structure, Concentration & Company Ranking, 2025
11.2. Core / Emerging / Regional / Adjacent Company Screening Methodology
11.3. Pure-Play Surface Guidance vs LINAC OEM Embedded Competitive Analysis
11.4. Offering & Deployment Coverage Matrix
11.5. Competitive Benchmarking — Module Breadth, Deployment Coverage, Geography & Installed Base
11.6. Brand-to-Parent De-Duplication & Ownership Map
11.7. Strategic Developments — Product Launches, Partnerships & Acquisitions, 2023–2026
11.8. Key Strategic Imperatives & Growth Strategies
Chapter 12. Company Profiles & Adjacent Market Watchlist
Core — Pure-Play & Leading Surface Guidance Suppliers
12.1. Vision RT Ltd.
12.2. C-RAD AB
12.3. Brainlab AG
Core — LINAC OEMs with Surface Guidance Offerings
12.4. Varian (Siemens Healthineers)
12.5. Elekta AB
12.6. Accuray Incorporated
Emerging & Regional Players
12.7. LAP GmbH Laser Applikationen
12.8. Emerging Optical Tracking & Regional Vendors
Adjacent Market — Referenced but Excluded
12.9. LINAC / CT-Sim / MR-Linac / Proton Machine OEMs
12.10. kV/CBCT, Ultrasound & Electromagnetic Tracking Providers
Chapter 13. Conclusion & Strategic Recommendations
13.1. Synthesis of Key Findings
13.2. White-Space Opportunities — Software Modules, In-Bore/MR & Proton, Emerging Markets
13.3. Recommendations for Surface Guidance Suppliers
13.4. Recommendations for LINAC & Proton OEMs
13.5. Recommendations for Radiation Oncology Centres & Procurement Teams
13.6. Recommendations for Investors & Corporate Development Teams
13.7. Future Outlook to 2035 — Software-Led, AI-Assisted & Broadly Deployed SGRT Ecosystem
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Surface Guided Radiation Therapy (SGRT) Devices Market predicted to witness an 8.7% CAGR during the forecast period for 2025-2034
Vision RT Ltd, Varian Medical Systems, Inc., C-Rad AB, Surface Imaging Solutions Limited, Civco Medical Instruments Co Inc. (MEDTECH, Inc.), Elekta AB
Product & Service, Application, Technology, Transplant Type, and End-User. are the key segments of the Surface Guided Radiation Therapy (SGRT) Devices
North America region is leading the Surface Guided Radiation Therapy (SGRT) Devices Market.